{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T08:00:11Z","timestamp":1792828811107,"version":"4.5.0"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T00:00:00Z","timestamp":1739318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T00:00:00Z","timestamp":1739318400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Australian Government Department of Education National Industry PhD Program","award":["#36403"],"award-info":[{"award-number":["#36403"]}]},{"name":"Australian Government Department of Education National Industry PhD Program","award":["#36403"],"award-info":[{"award-number":["#36403"]}]},{"DOI":"10.13039\/501100001795","name":"University of Southern Queensland","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001795","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Surviv"],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Prostate cancer is one of the most prevalent cancers worldwide. Active surveillance is a widely accepted treatment option for some localised prostate cancers. However, concerns have been raised about the experiences of men on this treatment given that almost 40% will discontinue without clinical indications. The objective of this review was to identify the lived experience of men on active surveillance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A systematic review and meta-synthesis, according to PRISMA guidelines. Studies were included if they reported qualitative data exploring the experiences of men undertaking active surveillance. Thomas and Harden\u2019s approach was undertaken for data synthesis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Five databases were searched identifying 3226 articles, and 13 studies met the inclusion criteria. Two overarching analytical themes were identified: (i) men on active surveillance live with a lack of certainty; and (ii) re-establishing agency drives resilience and facilitates confidence in active surveillance. Lack of certainty on active surveillance is derived from men feeling a loss of control over their health and\/or lives. This induces a stress response of ongoing worry and anxiety and loss of agency, further driving the stress cycle. Re-establishing agency alleviates the stress response, promotes resilience, and facilitates confidence in active surveillance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The experience of active surveillance is underpinned by ongoing lack of certainty diminishing agency and driving cyclical stress.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Implications for Cancer Survivors<\/jats:title>\n                    <jats:p>It is essential that health professionals better support men to establish and maintain confidence in active surveillance. Further research into men\u2019s perspectives of interventions and strategies that best facilitate agency and effectively support them is warranted.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11764-025-01748-x","type":"journal-article","created":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T17:16:11Z","timestamp":1739380571000},"page":"1462-1479","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The lived experience of active surveillance for prostate cancer: a systematic review and meta-synthesis"],"prefix":"10.1007","volume":"20","author":[{"given":"Russell J.","family":"Briggs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff","family":"Dunn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne K.","family":"Chambers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Jakimowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Heneka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,12]]},"reference":[{"key":"1748_CR1","unstructured":"Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Pi\u00f1eros M, Znaor A, Soerjomataram I, Bray F. Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https:\/\/gco.iarc.who.int\/today, accessed [15 Nov 2024]. 2024."},{"issue":"4","key":"1748_CR2","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1001\/jamaoncol.2022.7826","volume":"9","author":"S Chen","year":"2023","unstructured":"Chen S, et al. Estimates and projections of the global economic cost of 29 cancers in 204 countries and territories from 2020 to 2050. JAMA Oncol. 2023;9(4):465\u201372.","journal-title":"JAMA Oncol"},{"issue":"3","key":"1748_CR3","doi-asserted-by":"publisher","first-page":"e003901","DOI":"10.1136\/bmjopen-2013-003901","volume":"4","author":"S Watts","year":"2014","unstructured":"Watts S, et al. Depression and anxiety in prostate cancer: a systematic review and meta-analysis of prevalence rates. BMJ Open. 2014;4(3):e003901.","journal-title":"BMJ Open"},{"issue":"3","key":"1748_CR4","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1002\/pon.3909","volume":"25","author":"L Sharp","year":"2016","unstructured":"Sharp L, et al. Cancer-related symptoms predict psychological wellbeing among prostate cancer survivors: results from the PiCTure study. Psychooncology. 2016;25(3):282\u201391.","journal-title":"Psychooncology"},{"issue":"6","key":"1748_CR5","doi-asserted-by":"publisher","first-page":"e0198679","DOI":"10.1371\/journal.pone.0198679","volume":"13","author":"DP Smith","year":"2018","unstructured":"Smith DP, et al. Increased risk of suicide in New South Wales men with prostate cancer: analysis of linked population-wide data. PLoS One. 2018;13(6):e0198679.","journal-title":"PLoS One"},{"issue":"1","key":"1748_CR6","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1002\/1099-1611(200101\/02)10:1<66::AID-PON493>3.0.CO;2-Z","volume":"10","author":"S Steginga","year":"2001","unstructured":"Steginga S, et al. The supportive care needs of men with prostate cancer (2000). Psychooncology. 2001;10(1):66\u201375.","journal-title":"Psychooncology"},{"issue":"8","key":"1748_CR7","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1093\/jjco\/hyx066","volume":"47","author":"A Oba","year":"2017","unstructured":"Oba A, et al. Psychological distress in men with prostate cancer and their partners before and after cancer diagnosis: a longitudinal study. Jpn J Clin Oncol. 2017;47(8):735\u201342.","journal-title":"Jpn J Clin Oncol"},{"key":"1748_CR8","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/bju.15159","volume":"128","author":"J Dunn","year":"2021","unstructured":"Dunn J, et al. Prostate cancer survivorship essentials framework: guidelines for practitioners. BJU Int. 2021;128:18\u201329.","journal-title":"BJU Int"},{"issue":"17","key":"1748_CR9","doi-asserted-by":"publisher","first-page":"5730","DOI":"10.3390\/molecules27175730","volume":"27","author":"M Sekhoacha","year":"2022","unstructured":"Sekhoacha M, et al. Prostate cancer review: genetics, diagnosis, treatment options, and alternative approaches. Molecules. 2022;27(17):5730.","journal-title":"Molecules"},{"key":"1748_CR10","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.2147\/PPA.S271447","volume":"15","author":"GR Hale","year":"2021","unstructured":"Hale GR, et al. Measuring quality of life following robot-assisted radical prostatectomy. Patient Prefer Adherence. 2021;15:1373.","journal-title":"Patient Prefer Adherence"},{"issue":"6B","key":"1748_CR11","doi-asserted-by":"publisher","first-page":"E36","DOI":"10.1111\/bju.13179","volume":"117","author":"S Carlsson","year":"2016","unstructured":"Carlsson S, et al. Population-based study of long-term functional outcomes after prostate cancer treatment. BJU Int. 2016;117(6B):E36\u201345.","journal-title":"BJU Int"},{"key":"1748_CR12","unstructured":"Urological Society of Australia and New Zealand. PSA Testing Policy 2009 Executive Summary. 2009. Available from: http:\/\/www.usanz.org.au\/uploads\/29168\/ufiles\/USANZ_2009_PSA_Testing_Policy_Final1.pdf. Accessed 20 Jul 2024."},{"key":"1748_CR13","doi-asserted-by":"publisher","unstructured":"Wiegel T, Willemse PM, Cornford P. EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent. Eur Urol. 2021;79(2):243-62. https:\/\/doi.org\/10.1016\/j.eururo.2020.09.042.","DOI":"10.1016\/j.eururo.2020.09.042"},{"issue":"1","key":"1748_CR14","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1097\/JU.0000000000002757","volume":"208","author":"JA Eastham","year":"2022","unstructured":"Eastham JA, et al. Clinically localized prostate cancer: AUA\/ASTRO guideline, part I: Introduction, risk assessment, staging, and risk-based management. J Urol. 2022;208(1):10\u20138.","journal-title":"J Urol"},{"issue":"1","key":"1748_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12894-017-0290-7","volume":"17","author":"M Fitch","year":"2017","unstructured":"Fitch M, et al. Canadian Men\u2019s perspectives about active surveillance in prostate cancer: need for guidance and resources. BMC Urol. 2017;17(1):1\u201311.","journal-title":"BMC Urol"},{"issue":"12","key":"1748_CR16","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1002\/pon.5262","volume":"28","author":"M McIntosh","year":"2019","unstructured":"McIntosh M, et al. A systematic review of the unmet supportive care needs of men on active surveillance for prostate cancer. Psychooncology. 2019;28(12):2307\u201322.","journal-title":"Psychooncology"},{"issue":"7","key":"1748_CR17","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1002\/pon.5133","volume":"28","author":"L Matheson","year":"2019","unstructured":"Matheson L, et al. The psychological impact of being on a monitoring pathway for localised prostate cancer: a UK-wide mixed methods study. Psychooncology. 2019;28(7):1567\u201375.","journal-title":"Psychooncology"},{"issue":"1","key":"1748_CR18","doi-asserted-by":"publisher","first-page":"83","DOI":"10.21037\/tau.2017.12.24","volume":"7","author":"N Kinsella","year":"2018","unstructured":"Kinsella N, et al. Active surveillance for prostate cancer: a systematic review of contemporary worldwide practices. Transl Androl Urol. 2018;7(1):83.","journal-title":"Transl Androl Urol"},{"issue":"3","key":"1748_CR19","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1097\/MOU.0b013e32835eff24","volume":"23","author":"MW Kazer","year":"2013","unstructured":"Kazer MW, et al. Psychosocial aspects of active surveillance. Curr Opin Urol. 2013;23(3):273\u20137.","journal-title":"Curr Opin Urol"},{"issue":"Suppl 1","key":"1748_CR20","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1111\/bju.15129","volume":"126","author":"K Akakura","year":"2020","unstructured":"Akakura K, et al. Not all prostate cancer is the same - patient perceptions: an Asia-Pacific region study. BJU Int. 2020;126(Suppl 1):38\u201345.","journal-title":"BJU Int"},{"issue":"11","key":"1748_CR21","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1111\/j.1464-410X.2011.10200.x","volume":"108","author":"BJ Davison","year":"2011","unstructured":"Davison BJ, Goldenberg SL. Patient acceptance of active surveillance as a treatment option for low-risk prostate cancer. BJU Int. 2011;108(11):1787\u201393.","journal-title":"BJU Int"},{"issue":"3","key":"1748_CR22","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S0738-3991(02)00183-0","volume":"49","author":"EW Boberg","year":"2003","unstructured":"Boberg EW, et al. Assessing the unmet information, support and care delivery needs of men with prostate cancer. Patient Educ Couns. 2003;49(3):233\u201342.","journal-title":"Patient Educ Couns"},{"issue":"1","key":"1748_CR23","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1002\/pon.4469","volume":"27","author":"RM Hoffman","year":"2018","unstructured":"Hoffman RM, et al. Decision-making processes among men with low-risk prostate cancer: a survey study. Psychooncology. 2018;27(1):325\u201332.","journal-title":"Psychooncology"},{"issue":"8","key":"1748_CR24","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1177\/0272989X19883242","volume":"39","author":"RM Hoffman","year":"2019","unstructured":"Hoffman RM, et al. Selecting active surveillance: decision making factors for men with a low-risk prostate cancer. Med Decis Making. 2019;39(8):962\u201374.","journal-title":"Med Decis Making"},{"issue":"3","key":"1748_CR25","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.pec.2011.11.009","volume":"87","author":"BJ Davison","year":"2012","unstructured":"Davison BJ, Breckon E. Factors influencing treatment decision making and information preferences of prostate cancer patients on active surveillance. Patient Educ Couns. 2012;87(3):369\u201374.","journal-title":"Patient Educ Couns"},{"issue":"2","key":"1748_CR26","doi-asserted-by":"publisher","first-page":"e101","DOI":"10.1016\/S1569-9056(18)30921-7","volume":"17","author":"O Bergengren","year":"2018","unstructured":"Bergengren O, et al. Satisfaction with care among men with localized prostate cancer-a nationwide population based study. Eur Urol Suppl. 2018;17(2):e101.","journal-title":"Eur Urol Suppl"},{"key":"1748_CR27","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.","journal-title":"BMJ"},{"issue":"16","key":"1748_CR28","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1200\/JCO.2010.32.8112","volume":"29","author":"JJ Tosoian","year":"2011","unstructured":"Tosoian JJ, et al. Active surveillance program for prostate cancer: an update of the Johns Hopkins experience. J Clin Oncol. 2011;29(16):2185\u201390.","journal-title":"J Clin Oncol"},{"key":"1748_CR29","doi-asserted-by":"publisher","first-page":"e235","DOI":"10.1200\/EDBK_159244","volume":"36","author":"JJ Tosoian","year":"2016","unstructured":"Tosoian JJ, et al. Active surveillance of prostate cancer: use, outcomes, imaging, and diagnostic tools. Am Soc Clin Oncol Educ Book. 2016;36:e235\u201345.","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"3","key":"1748_CR30","doi-asserted-by":"publisher","first-page":"520","DOI":"10.5195\/jmla.2021.1260","volume":"109","author":"T Gotschall","year":"2021","unstructured":"Gotschall T. EndNote 20 desktop version. J Med Libr Assoc: JMLA. 2021;109(3):520.","journal-title":"J Med Libr Assoc: JMLA"},{"key":"1748_CR31","unstructured":"Covidence systematic review software, Veritas Health Innovation, Melbourne, Australia.\u00a02023. Available at www.covidence.org. Accessed 28 Jan 2024."},{"key":"1748_CR32","unstructured":"Critical Appraisal Skills Programme (CASP), CASP qualitative checklist. Critical Appraisal Skills Programme. 2018."},{"issue":"1","key":"1748_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2288-8-45","volume":"8","author":"J Thomas","year":"2008","unstructured":"Thomas J, Harden A. Methods for the thematic synthesis of qualitative research in systematic reviews. BMC Med Res Methodol. 2008;8(1):1\u201310.","journal-title":"BMC Med Res Methodol"},{"issue":"6","key":"1748_CR34","first-page":"5459","volume":"30","author":"O Eymech","year":"2022","unstructured":"Eymech O, et al. An exploration of wellbeing in men diagnosed with prostate cancer undergoing active surveillance: a qualitative study. Support Care Cancer. 2022;30(6):5459\u201368.","journal-title":"Support Care Cancer"},{"issue":"1","key":"1748_CR35","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1093\/fampra\/cmw123","volume":"34","author":"A Mallapareddi","year":"2017","unstructured":"Mallapareddi A, et al. Active surveillance for low-risk localized prostate cancer: what do men and their partners think? Fam Pract. 2017;34(1):90\u20137.","journal-title":"Fam Pract"},{"issue":"3\u20134","key":"1748_CR36","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1111\/j.1365-2702.2010.03489.x","volume":"20","author":"MW Kazer","year":"2011","unstructured":"Kazer MW, et al. The needs for men undergoing active surveillance (AS) for prostate cancer: results of a focus group study. J Clin Nurs. 2011;20(3\u20134):581\u20136.","journal-title":"J Clin Nurs"},{"issue":"2","key":"1748_CR37","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.pec.2017.08.022","volume":"101","author":"S Loeb","year":"2018","unstructured":"Loeb S, et al. Informational needs during active surveillance for prostate cancer: a qualitative study. Patient Educ Couns. 2018;101(2):241\u20137.","journal-title":"Patient Educ Couns"},{"issue":"12","key":"1748_CR38","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1002\/pon.3576","volume":"23","author":"C O'Callaghan","year":"2014","unstructured":"O\u2019Callaghan C, et al. \u2018What is this active surveillance thing?\u2019 Men\u2019s and partners\u2019 reactions to treatment decision making for prostate cancer when active surveillance is the recommended treatment option. Psychooncology. 2014;23(12):1391\u20138.","journal-title":"Psychooncology"},{"issue":"4","key":"1748_CR39","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1177\/1049732309332692","volume":"19","author":"JL Oliffe","year":"2009","unstructured":"Oliffe JL, et al. The self-management of uncertainty among men undertaking active surveillance for low-risk prostate cancer. Qual Health Res. 2009;19(4):432\u201343.","journal-title":"Qual Health Res"},{"issue":"1","key":"1748_CR40","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1188\/09.ONF.89-96","volume":"36","author":"BJ Davison","year":"2009","unstructured":"Davison BJ, et al. Factors influencing men undertaking active surveillance for the management of low-risk prostate cancer. Oncol Nurs Forum. 2009;36(1):89\u201396.","journal-title":"Oncol Nurs Forum"},{"issue":"1","key":"1748_CR41","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12894-017-0225-3","volume":"17","author":"EM Mader","year":"2017","unstructured":"Mader EM, et al. Qualitative insights into how men with low-risk prostate cancer choosing active surveillance negotiate stress and uncertainty. BMC Urol. 2017;17(1):35.","journal-title":"BMC Urol"},{"issue":"4","key":"1748_CR42","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s40271-014-0066-z","volume":"7","author":"Z Berger","year":"2014","unstructured":"Berger Z, et al. Characteristics and experiences of patients with localized prostate cancer who left an active surveillance program. Patient. 2014;7(4):427\u201336.","journal-title":"Patient"},{"issue":"5","key":"1748_CR43","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1097\/00002820-200409000-00001","volume":"27","author":"DE Bailey","year":"2004","unstructured":"Bailey DE, et al. Uncertainty intervention for watchful waiting in prostate cancer. Cancer Nurs. 2004;27(5):339\u201346.","journal-title":"Cancer Nurs"},{"issue":"1","key":"1748_CR44","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1037\/a0029934","volume":"32","author":"LW Mroz","year":"2013","unstructured":"Mroz LW, Oliffe JL, Davison BJ. Masculinities and patient perspectives of communication about active surveillance for prostate cancer. Health Psychol. 2013;32(1):83\u201390.","journal-title":"Health Psychol"},{"issue":"4","key":"1748_CR45","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1002\/pon.3444","volume":"23","author":"RJ Volk","year":"2014","unstructured":"Volk RJ, et al. \u201cIt\u2019s not like you just had a heart attack\u201d: decision-making about active surveillance by men with localized prostate cancer. Psychooncology. 2014;23(4):467\u201372.","journal-title":"Psychooncology"},{"issue":"3","key":"1748_CR46","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/ijun.12242","volume":"14","author":"K Donachie","year":"2020","unstructured":"Donachie K, et al. Optimizing psychosocial support in prostate cancer patients during active surveillance. Int J Urol Nurs. 2020;14(3):115\u201323.","journal-title":"Int J Urol Nurs"},{"key":"1748_CR47","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.3389\/fpsyg.2016.01272","volume":"7","author":"JW Moore","year":"2016","unstructured":"Moore JW. What is the sense of agency and why does it matter? Front Psychol. 2016;7:1272.","journal-title":"Front Psychol"},{"issue":"3","key":"1748_CR48","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/iju.13016","volume":"23","author":"J Romero-Otero","year":"2016","unstructured":"Romero-Otero J, et al. Active surveillance for prostate cancer. Int J Urol. 2016;23(3):211\u20138.","journal-title":"Int J Urol"},{"key":"1748_CR49","doi-asserted-by":"publisher","unstructured":"VandenBos GR. (Ed.). APA dictionary of psychology (2nd ed.). American Psychological Association. 2015. https:\/\/doi.org\/10.1037\/14646-000.","DOI":"10.1037\/14646-000"},{"key":"1748_CR50","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.pneurobio.2017.05.004","volume":"156","author":"A Peters","year":"2017","unstructured":"Peters A, McEwen BS, Friston K. Uncertainty and stress: why it causes diseases and how it is mastered by the brain. Prog Neurobiol. 2017;156:164\u201388.","journal-title":"Prog Neurobiol"},{"key":"1748_CR51","doi-asserted-by":"publisher","unstructured":"Sch\u00e4fer A, Pels F, Kleinert J. Effects of different coping strategies on the psychological and physiological stress reaction: an experimental study. Eur J Health Psychol. 2020;27(3):109\u201323. https:\/\/doi.org\/10.1027\/2512-8442\/a000056.","DOI":"10.1027\/2512-8442\/a000056"},{"key":"1748_CR52","doi-asserted-by":"publisher","unstructured":"Chambers SK, Hyde MK, Oliffe JL, Zajdlewicz L, Lowe A, Wootten AC, Dunn J. Measuring masculinity in the context of chronic disease.\u00a0Psychol Men Masculinity. 2016;17(3):228\u201342. https:\/\/doi.org\/10.1037\/men0000018.","DOI":"10.1037\/men0000018"},{"key":"1748_CR53","doi-asserted-by":"publisher","unstructured":"Kampourakis K, et al. 19The psychology of (Un)Certainty, in uncertainty: How it makes science advance. Oxford University Press. 2019,. p. 0. https:\/\/doi.org\/10.1093\/oso\/9780190871666.003.0002.","DOI":"10.1093\/oso\/9780190871666.003.0002"},{"issue":"2","key":"1748_CR54","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1002\/pon.5264","volume":"29","author":"BC Goodwin","year":"2020","unstructured":"Goodwin BC, et al. The role of masculinities in psychological and emotional help seeking by men with prostate cancer. Psychooncology. 2020;29(2):356\u201363.","journal-title":"Psychooncology"},{"issue":"1","key":"1748_CR55","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/bju.14707","volume":"124","author":"SW Merriel","year":"2019","unstructured":"Merriel SW, et al. Best practice in active surveillance for men with prostate cancer: a Prostate Cancer UK consensus statement. BJU Int. 2019;124(1):47\u201354.","journal-title":"BJU Int"},{"key":"1748_CR56","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1007\/s13193-012-0142-6","volume":"3","author":"M Adhyam","year":"2012","unstructured":"Adhyam M, Gupta AK. A review on the clinical utility of PSA in cancer prostate. Indian J Surg Oncol. 2012;3:120\u20139.","journal-title":"Indian J Surg Oncol"},{"key":"1748_CR57","unstructured":"Australia, P.C.F.o. and C.C.A.P.T.G.E.A. Panel, PSA testing and early management of test-detected prostate cancer: clinical practice guidelines. Prostate Cancer Foundation of Australia Sydney NSW, Australia. 2016."},{"key":"1748_CR58","volume-title":"Prostate cancer in Australian and New Zealand men: patterns of care within PCOR-ANZ","author":"N Papa","year":"2021","unstructured":"Papa N, et al. Prostate cancer in Australian and New Zealand men: patterns of care within PCOR-ANZ. Melbourne, Vic: Monash University and Movember; 2021."},{"issue":"3","key":"1748_CR59","first-page":"134","volume":"52","author":"TC Davis","year":"2002","unstructured":"Davis TC, et al. Health literacy and cancer communication. CA: Cancer J Clin. 2002;52(3):134\u201349.","journal-title":"CA: Cancer J Clin"},{"issue":"6","key":"1748_CR60","doi-asserted-by":"publisher","first-page":"290","DOI":"10.5694\/j.1326-5377.1999.tb123656.x","volume":"171","author":"EA Lobb","year":"1999","unstructured":"Lobb EA, et al. Communicating prognosis in early breast cancer: do women understand the language used? Med J Aust. 1999;171(6):290\u20134.","journal-title":"Med J Aust"},{"issue":"3","key":"1748_CR61","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/pon.1745","volume":"20","author":"MA Hillen","year":"2011","unstructured":"Hillen MA, De Haes HC, Smets EM. Cancer patients\u2019 trust in their physician\u2014a review. Psychooncology. 2011;20(3):227\u201341.","journal-title":"Psychooncology"},{"key":"1748_CR62","doi-asserted-by":"publisher","unstructured":"Orom H, Homish DL, Homish GG, Underwood III W. Quality of physician-patient relationships is associated with the influence of physician treatment recommendations among patients with prostate cancer who chose active surveillance.\u00a0Urol Oncol: Semin Orig Investig. 2014;32(4):396\u2013402. Elsevier.\u00a0https:\/\/doi.org\/10.1016\/j.urolonc.2013.09.018.","DOI":"10.1016\/j.urolonc.2013.09.018"},{"issue":"4","key":"1748_CR63","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1093\/fampra\/cmh419","volume":"21","author":"J Howie","year":"2004","unstructured":"Howie J, Heaney D, Maxwell M. Quality, core values and the general practice consultation: issues of definition, measurement and delivery. Fam Pract. 2004;21(4):458\u201368.","journal-title":"Fam Pract"},{"issue":"4","key":"1748_CR64","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.ijmedinf.2005.12.002","volume":"76","author":"BR Shaw","year":"2007","unstructured":"Shaw BR, et al. Doctor\u2013patient relationship as motivation and outcome: examining uses of an interactive cancer communication system. Int J Med Informatics. 2007;76(4):274\u201382.","journal-title":"Int J Med Informatics"},{"issue":"3","key":"1748_CR65","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1080\/10410230902804125","volume":"24","author":"NO Rosen","year":"2009","unstructured":"Rosen NO, Kn\u00e4uper B. A little uncertainty goes a long way: state and trait differences in uncertainty interact to increase information seeking but also increase worry. Health Commun. 2009;24(3):228\u201338.","journal-title":"Health Commun"},{"issue":"7239","key":"1748_CR66","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1136\/bmj.320.7239.909","volume":"320","author":"GM Leydon","year":"2000","unstructured":"Leydon GM, et al. Cancer patients\u2019 information needs and information seeking behaviour: in depth interview study. BMJ. 2000;320(7239):909\u201313.","journal-title":"BMJ"},{"issue":"9","key":"1748_CR67","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1080\/10810730.2016.1184358","volume":"21","author":"LT Wigfall","year":"2016","unstructured":"Wigfall LT, Friedman DB. Cancer information seeking and cancer-related health outcomes: a scoping review of the health information national trends survey literature. J Health Commun. 2016;21(9):989\u20131005.","journal-title":"J Health Commun"},{"key":"1748_CR68","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1007\/s13187-015-0802-7","volume":"31","author":"LJ Finney Rutten","year":"2016","unstructured":"Finney Rutten LJ, et al. Cancer-related information seeking among cancer survivors: trends over a decade (2003\u20132013). J Cancer Educ. 2016;31:348\u201357.","journal-title":"J Cancer Educ"}],"container-title":["Journal of Cancer Survivorship"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11764-025-01748-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11764-025-01748-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11764-025-01748-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T09:03:37Z","timestamp":1784192617000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11764-025-01748-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,12]]},"references-count":68,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["1748"],"URL":"https:\/\/doi.org\/10.1007\/s11764-025-01748-x","relation":{},"ISSN":["1932-2259","1932-2267"],"issn-type":[{"value":"1932-2259","type":"print"},{"value":"1932-2267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,12]]},"assertion":[{"value":"12 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}